Gene Editing Updates - CRISPR, Intellia, and Beam
Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/rp9e1V8dfPk.
We revisit gene editing stocks once per year because things move very slowly in this space. While there may be upwards of 27 gene editing stocks out there, our focus is on the three biggest – Beam Therapeutics BEAM, Intellia Therapeutics NTLA, and CRISPR Therapeutics CRSP. Each of these companies is racing to bring treatments to market…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.